DNAG Good News from Germany Biofrontera: Rapid progress in Clinical Phase IIb/III trial for actinic keratosis <A HREF="http://www.biofrontera.com/cms/index.php?id=51&L=1" target="_blank">http://www.biofrontera.com/cms/index.php?id=51&L=1</A>